14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £2.01 £2.74 Thursday, 2nd May 2024 IMM.L stock ended at £2.04. This is 0.246% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.98% from a day low at £2.01 to a day high of £2.11.
90 days £0.82 £3.00
52 weeks £0.82 £3.80

Historical Immupharma Plc prices

Date Open High Low Close Volume
Feb 20, 2024 £1.17 £1.25 £1.12 £1.13 433 422
Feb 19, 2024 £1.29 £1.29 £1.05 £1.18 4 294 394
Feb 16, 2024 £1.29 £1.29 £1.21 £1.24 527 179
Feb 15, 2024 £1.27 £1.27 £1.21 £1.21 349 206
Feb 14, 2024 £1.21 £1.25 £1.21 £1.22 623 055
Feb 13, 2024 £1.30 £1.30 £1.21 £1.25 461 430
Feb 12, 2024 £1.45 £1.45 £1.21 £1.27 2 354 216
Feb 09, 2024 £1.34 £1.35 £1.26 £1.31 1 586 369
Feb 08, 2024 £1.33 £1.34 £1.30 £1.31 218 418
Feb 07, 2024 £1.26 £1.45 £1.26 £1.38 966 867
Feb 06, 2024 £1.33 £1.36 £1.26 £1.28 743 395
Feb 05, 2024 £1.45 £1.45 £1.30 £1.38 565 298
Feb 02, 2024 £1.45 £1.45 £1.29 £1.36 716 945
Feb 01, 2024 £1.37 £1.44 £1.32 £1.36 2 262 265
Jan 31, 2024 £1.41 £1.43 £1.30 £1.34 1 324 867
Jan 30, 2024 £1.40 £1.54 £1.40 £1.43 1 164 766
Jan 29, 2024 £1.65 £1.65 £1.40 £1.46 1 374 155
Jan 26, 2024 £1.52 £1.65 £1.40 £1.52 9 467 466
Jan 25, 2024 £1.60 £1.70 £1.42 £1.58 8 632 514
Jan 24, 2024 £1.60 £1.62 £1.56 £1.59 1 248 540
Jan 23, 2024 £1.61 £1.68 £1.60 £1.63 867 412
Jan 22, 2024 £1.62 £1.78 £1.60 £1.78 534 003
Jan 19, 2024 £1.66 £1.80 £1.60 £1.80 813 904
Jan 18, 2024 £1.60 £1.76 £1.60 £1.76 1 334 878
Jan 17, 2024 £1.65 £1.70 £1.63 £1.63 225 735
Click to get the best stock tips daily for free!

About Immupharma Plc

Immupharma Plc ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a... IMM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT